These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22791367)

  • 21. Perivascular stem cell niche in head and neck cancer.
    Ritchie KE; Nör JE
    Cancer Lett; 2013 Sep; 338(1):41-6. PubMed ID: 22842095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
    Bourguignon LY; Wong G; Shiina M
    J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties.
    Martens-de Kemp SR; Brink A; Stigter-van Walsum M; Damen JM; Rustenburg F; Wu T; van Wieringen WN; Schuurhuis GJ; Braakhuis BJ; Slijper M; Brakenhoff RH
    Stem Cell Res; 2013 May; 10(3):477-88. PubMed ID: 23523931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
    Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
    Clay MR; Tabor M; Owen JH; Carey TE; Bradford CR; Wolf GT; Wicha MS; Prince ME
    Head Neck; 2010 Sep; 32(9):1195-201. PubMed ID: 20073073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
    Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.
    Wu MJ; Jan CI; Tsay YG; Yu YH; Huang CY; Lin SC; Liu CJ; Chen YS; Lo JF; Yu CC
    Mol Cancer; 2010 Oct; 9():283. PubMed ID: 20979610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.
    Han J; Fujisawa T; Husain SR; Puri RK
    BMC Cancer; 2014 Mar; 14():173. PubMed ID: 24612587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase.
    Kamarajan P; Rajendiran TM; Kinchen J; Bermúdez M; Danciu T; Kapila YL
    J Proteome Res; 2017 Mar; 16(3):1315-1326. PubMed ID: 28168879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.
    Koukourakis MI; Giatromanolaki A; Tsakmaki V; Danielidis V; Sivridis E
    Br J Cancer; 2012 Feb; 106(5):846-53. PubMed ID: 22333601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
    Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
    J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
    Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
    PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer.
    Leong HS; Chong FT; Sew PH; Lau DP; Wong BH; Teh BT; Tan DS; Iyer NG
    Stem Cells Transl Med; 2014 Sep; 3(9):1055-65. PubMed ID: 25024430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
    Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
    Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells in head and neck squamous cell carcinoma: a review.
    Satpute PS; Hazarey V; Ahmed R; Yadav L
    Asian Pac J Cancer Prev; 2013; 14(10):5579-87. PubMed ID: 24289547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.